Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

- PMLiVE

Pharma lobbying in the US

Is it a matter of freedom of speech?

Novartis building

FDA panel backs Novartis’ secukinumab for psoriasis

Drug has outperformed Amgen’s Enbrel in clinical trials

- PMLiVE

AbbVie and Shire bring merger plans to a close

Blames tax changes in the US

- PMLiVE

EMA offers orphan drug benefits for Ebola research

Incentives to encourage development of new treatments for the virus

- PMLiVE

Salary survey now open – how will you measure up?

Take part for a chance to win a Kindle Fire HD tablet

- PMLiVE

Parkinson’s UK appoints Arthur Roach as research director

He brings experience from Merck Serono and the Geneva Pharma Network

- PMLiVE

Red Door promotes Matt Lowe and Katy Pogson

Kate Aldous and Sarah Aldridge also move up at the Creston Health agency

- PMLiVE

Janssen’s blood cancer drug Imbruvica approved in Europe

European commission licenses the first-in-class drug for two rare diseases

- PMLiVE

Regeneron top science employer, says survey

Ranked highest for third year in a row

- PMLiVE

FDA votes to keep severe warning on Pfizer’s Chantix

Will not relax anti-smoking drug's side effect warning

Kantar Health adds to UK team

Group director, junior designers and graduate research team appointed

- PMLiVE

Amgen files lawsuit to block PCSK9 rivals

Firm suing Sanofi and Regeneron for patent infringement

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links